Latest AMGN reports update at 2024-02-14: 2023 ∙ 2022 ∙ 2021
  1. Home
  2. Stock quotes
  3. Stock Amgen
Amgen logo

Amgen AMGN

$ 269.98 0.22%
mail-toReport an Error

Country

 usaUSA

IPO year

 1983

Industry

 Drug manufacturers

Stock Exchange

 NASDAQ GLOBALSPB

CEO

 Mr. Robert Bradway

Employees in the company

 23 400

Shares

 535 M

Market Cap[1]

 $ 144 B

EBITDA (LTM)

 $ 12.4 B

P/E (LTM)

 19.3

P/S (LTM)

 5.19

EPS (LTM)

 13.25

Amgen is a biopharmaceutical company founded in the USA in 1980. The company is engaged in the development and production of drugs for the treatment of serious diseases such as cancer, rheumatoid arthritis, and osteoporosis.

AMGN is a leading provider of biotechnology products and has over 20,000 employees worldwide. The company has operations in over 100 countries and produces its products in facilities around the world.

The main goal of Amgen is to improve the lives of patients by developing innovative drugs that help fight serious illnesses. The company invests billions of dollars annually in research and development to find new treatment options.

AMGN also advocates for sustainability and environmental protection. The company is committed to reducing its CO2 emissions and making its production processes as environmentally friendly as possible. Amgen is also involved in the community and supports various programs to improve healthcare and education.

Overall, Amgen is an innovative and responsible company dedicated to developing new treatment options for serious illnesses while also striving to protect the environment and support the community.

Other stocks of industry "Drug manufacturers"

Issuer Price % 24h Market Cap Exchange Country
Amryt Pharma plc Amryt Pharma plc
AMYT
 		$ 14.7 - $ 621 M Nasdaq Global Select Market britainBritain
Collegium Pharmaceutical Collegium Pharmaceutical
COLL
 		$ 36.42 1.62 % $ 1.18 B Nasdaq Global Select Market usaUSA
Aerie Pharmaceuticals Aerie Pharmaceuticals
AERI
 		$ 15.25 - $ 754 M Nasdaq Global Market,SPB usaUSA
PetIQ PetIQ
PETQ
 		$ 13.6 1.64 % $ 400 M Nasdaq Global Select Market,SPB usaUSA
Teligent, Inc. Teligent, Inc.
TLGT
 		$ 0.173 -13.85 % $ 16.1 M Nasdaq Global Select Market usaUSA
Recro Pharma Recro Pharma
REPH
 		$ 1.4 -4.76 % $ 65.3 M Nasdaq Global Select Market usaUSA
FSD Pharma FSD Pharma
HUGE
 		$ 0.48 1.24 % $ 69.7 M Nasdaq Capital Market canadaCanada
Athenex Athenex
ATNX
 		$ 0.2 -23.39 % $ 1.76 M Nasdaq Global Select Market usaUSA
PLx Pharma PLx Pharma
PLXP
 		$ 0.09 -27.8 % $ 2.56 M Nasdaq Capital Market usaUSA
Shineco, Inc. Shineco, Inc.
TYHT
 		$ 11.09 -3.90 % $ 97.2 M Nasdaq Global Select Market chinaChina
Supernus Pharmaceuticals Supernus Pharmaceuticals
SUPN
 		$ 30.07 2.59 % $ 1.61 B Nasdaq Global Select Market,SPB usaUSA
Lannett Company Lannett Company
LCI
 		$ 0.66 1.15 % $ 7.11 M NYSE usaUSA
Viatris Viatris
VTRS
 		$ 11.57 0.87 % $ 14 B Nasdaq Global Select Market,SPB usaUSA
GW Pharmaceuticals plc GW Pharmaceuticals plc
GWPH
 		$ 218.96 - $ 6.81 B Nasdaq Global Select Market britainBritain
cbdMD cbdMD
YCBD
 		$ 0.87 -3.21 % $ 1.76 M NYSE American usaUSA
Zomedica Corp. Zomedica Corp.
ZOM
 		$ 0.13 2.23 % $ 127 M NYSE American usaUSA
Adamas Pharmaceuticals, Inc. Adamas Pharmaceuticals, Inc.
ADMS
 		$ 8.22 - $ 376 M Nasdaq Global Market usaUSA
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc.
FLXN
 		$ 9.12 - $ 459 M Nasdaq Global Market usaUSA
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
 		$ 4.5 1.35 % $ 17.8 M Nasdaq Capital Market chinaChina
Kindred Biosciences, Inc. Kindred Biosciences, Inc.
KIN
 		$ 9.25 0.11 % $ 419 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.